BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20199975)

  • 1. Prognostic value of computed tomography morphologic characteristics in stage I non-small-cell lung cancer.
    Meniga IN; Tiljak MK; Ivankovic D; Aleric I; Zekan M; Hrabac P; Mazuranic I; Puljic I
    Clin Lung Cancer; 2010 Mar; 11(2):98-104. PubMed ID: 20199975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer.
    Kim HK; Choi YS; Kim K; Shim YM; Jeong SY; Lee KS; Kwon OJ; Kim J
    J Thorac Oncol; 2009 Oct; 4(10):1242-6. PubMed ID: 19687762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S; Nuyttens JJ; Maat AP; Birim Ö; Aerts JG; Bogers AJ; Takkenberg JJ
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.
    Lindell RM; Hartman TE; Swensen SJ; Jett JR; Midthun DE; Tazelaar HD; Mandrekar JN
    Radiology; 2007 Feb; 242(2):555-62. PubMed ID: 17255425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography-guided percutaneous microwave ablation of patients 75 years of age and older with early-stage nonsmall cell lung cancer.
    Han X; Yang X; Ye X; Liu Q; Huang G; Wang J; Li W; Zheng A; Ni Y; Men M
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e56-60. PubMed ID: 26728675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.
    Yamamoto T; Kadoya N; Shirata Y; Koto M; Sato K; Matsushita H; Sugawara T; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Ito K; Katagiri Y; Takeda K; Jingu K
    Radiat Oncol; 2015 Feb; 10():35. PubMed ID: 25886315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Xie HJ; Zhang X; Mo YX; Long H; Rong TH; Su XD
    Ann Surg Oncol; 2019 Aug; 26(8):2401-2408. PubMed ID: 31054041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
    Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
    J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of clinical features and prognostic factors in resected bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Volpino P; Cavallaro A; Cangemi R; Chiarotti F; De Cesare A; Fiori E; Bononi M; Vigliarolo R; Cangemi V
    Anticancer Res; 2003; 23(6D):4959-65. PubMed ID: 14981952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer.
    Koizumi T; Tsushima K; Tanabe T; Agatsuma T; Yokoyama T; Ito M; Kanda S; Kobayashi T; Yasuo M
    Respiration; 2015; 90(1):47-55. PubMed ID: 26044954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental lung carcinoma detected at CT in patients selected for lung volume reduction surgery to treat severe pulmonary emphysema.
    Rozenshtein A; White CS; Austin JH; Romney BM; Protopapas Z; Krasna MJ
    Radiology; 1998 May; 207(2):487-90. PubMed ID: 9577499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases.
    Al-Sarraf N; Gately K; Lucey J; Aziz R; Doddakula K; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):892-7. PubMed ID: 18722132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of endoscopic ultrasound-fine needle aspiration of left adrenal masses in established or suspected lung cancer.
    Bodtger U; Vilmann P; Clementsen P; Galvis E; Bach K; Skov BG
    J Thorac Oncol; 2009 Dec; 4(12):1485-9. PubMed ID: 19752760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
    Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
    Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.